Carbapenem-Resistant Bacteria Recovered from Faeces of Dairy Cattle in the High Plains Region of the USA

Objective A study was conducted to recover carbapenem-resistant bacteria from the faeces of dairy cattle and identify the underlying genetic mechanisms associated with reduced phenotypic susceptibility to carbapenems. Methods One hundred and fifty-nine faecal samples from dairy cattle were screened for carbapenem-resistant bacteria. Phenotypic screening was conducted on two media containing ertapenem. The isolates from the screening step were characterised via disk diffusion, Modified Hodge, and Carba NP assays. Carbapenem-resistant bacteria and carbapenemase-producing isolates were subjected to Gram staining and biochemical testing to include Gram-negative bacilli. Whole genome sequencing was performed on bacteria that exhibited either a carbapenemase-producing phenotype or were not susceptible to ertapenem and were presumptively Enterobacteriaceae. Results Of 323 isolates collected from the screening media, 28 were selected for WGS; 21 of which were based on a carbapenemase-producing phenotype and 7 were presumptively Enterobacteriaceae and not susceptible to ertapenem. Based on analysis of WGS data, isolates included: 3 Escherichia coli harbouring blaCMY-2 and truncated ompF genes; 8 Aeromonas harbouring blacphA-like genes; 1 Acinetobacter baumannii harbouring a novel blaOXA gene (blaOXA-497); and 6 Pseudomonas with conserved domains of various carbapenemase-producing genes. Conclusions Carbapenem resistant bacteria appear to be rare in cattle. Nonetheless, carbapenem-resistant bacteria were detected across various genera and were found to harbour a variety of mechanisms conferring reduced susceptibility. The development and dissemination of carbapenem-resistant bacteria in livestock would have grave implications for therapeutic treatment options in human medicine; thus, continued monitoring of carbapenem susceptibility among enteric bacteria of livestock is warranted.

[1]  Efsa Publication EFSA BIOHAZ Panel (EFSA Panel on Biological Hazards), 2013. Scientific Opinion on Carbapenem resistance in food animal ecosystems , 2014 .

[2]  Thierry Naas,et al.  Global Spread of Carbapenemase-producing Enterobacteriaceae , 2011, Emerging infectious diseases.

[3]  P. Nordmann,et al.  In Vivo Acquisition of High-Level Resistance to Imipenem in Escherichia coli , 2004, Journal of Clinical Microbiology.

[4]  P. Nordmann,et al.  Contribution of Acquired Carbapenem-Hydrolyzing Oxacillinases to Carbapenem Resistance in Acinetobacter baumannii , 2005, Antimicrobial Agents and Chemotherapy.

[5]  P. Nordmann,et al.  Carbapenem resistance in Enterobacteriaceae: here is the storm! , 2012, Trends in molecular medicine.

[6]  H. Bayley,et al.  Altered Antibiotic Transport in OmpC Mutants Isolated from a Series of Clinical Strains of Multi-Drug Resistant E. coli , 2011, PloS one.

[7]  I. Booth,et al.  Protected environments allow parallel evolution of a bacterial pathogen in a patient subjected to long‐term antibiotic therapy , 2001, Molecular microbiology.

[8]  E. Denamur,et al.  Escherichia , 2020, Definitions.

[9]  B. Guerra,et al.  Salmonella enterica subsp. enterica producing VIM-1 carbapenemase isolated from livestock farms. , 2013, The Journal of antimicrobial chemotherapy.

[10]  S. Rasmussen,et al.  Identification of acquired antimicrobial resistance genes , 2012, The Journal of antimicrobial chemotherapy.

[11]  P. Nordmann,et al.  The carbapenemase threat in the animal world: the wrong culprit. , 2014, The Journal of antimicrobial chemotherapy.

[12]  K. Bush,et al.  Carbapenemases: the Versatile β-Lactamases , 2007, Clinical Microbiology Reviews.

[13]  L. Simmons,et al.  Patient engagement as a risk factor in personalized health care: a systematic review of the literature on chronic disease , 2014, Genome Medicine.

[14]  A. Zavascki,et al.  Performance of Quantification of Modified Hodge Test: An Evaluation with Klebsiella pneumoniae Carbapenemase-Producing Enterobacteriaceae Isolates , 2014, BioMed research international.

[15]  Michael Bell,et al.  Vital Signs: Carbapenem-Resistant Enterobacteriaceae , 2013, MMWR. Morbidity and mortality weekly report.

[16]  B. Norby,et al.  Changes in antimicrobial susceptibility in a population of Escherichia coli isolated from feedlot cattle administered ceftiofur crystalline-free acid. , 2007, American journal of veterinary research.

[17]  M. Vaneechoutte,et al.  OXA-23-producing Acinetobacter species from horses: a public health hazard? , 2012, The Journal of antimicrobial chemotherapy.

[18]  J. Rolain,et al.  ARG-ANNOT, a New Bioinformatic Tool To Discover Antibiotic Resistance Genes in Bacterial Genomes , 2013, Antimicrobial Agents and Chemotherapy.

[19]  A. Carattoli Animal reservoirs for extended spectrum beta-lactamase producers. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[20]  J. Stetefeld,et al.  Modeling of Molecular Interaction between Apoptin, BCR-Abl and CrkL - An Alternative Approach to Conventional Rational Drug Design , 2012, PloS one.

[21]  I. Henriques,et al.  Low Prevalence of Carbapenem-Resistant Bacteria in River Water: Resistance Is Mostly Related to Intrinsic Mechanisms. , 2015, Microbial drug resistance.

[22]  P. Nordmann,et al.  The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[23]  S. Pournaras,et al.  Inhibitor-based methods for the detection of KPC carbapenemase-producing Enterobacteriaceae in clinical practice by using boronic acid compounds. , 2010, The Journal of antimicrobial chemotherapy.

[24]  D. Livermore The zeitgeist of resistance. , 2007, The Journal of antimicrobial chemotherapy.

[25]  Torsten Seemann,et al.  Prokka: rapid prokaryotic genome annotation , 2014, Bioinform..

[26]  Justin Zobel,et al.  SRST2: Rapid genomic surveillance for public health and hospital microbiology labs , 2014, bioRxiv.

[27]  R. Rosselló-Móra,et al.  Shifting the genomic gold standard for the prokaryotic species definition , 2009, Proceedings of the National Academy of Sciences.

[28]  D. Livermore,et al.  Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  Matthew N. Benedict,et al.  ITEP: An integrated toolkit for exploration of microbial pan-genomes , 2014, BMC Genomics.

[30]  Daniel Falush,et al.  Sex and virulence in Escherichia coli: an evolutionary perspective , 2006, Molecular microbiology.

[31]  P. Nordmann,et al.  Detection of Carbapenemase Producers in Enterobacteriaceae by Use of a Novel Screening Medium , 2012, Journal of Clinical Microbiology.

[32]  G. Rossolini,et al.  Distribution of cphA or related carbapenemase-encoding genes and production of carbapenemase activity in members of the genus Aeromonas , 1995, Antimicrobial agents and chemotherapy.

[33]  P. Nordmann,et al.  Evaluation of the RAPIDEC® CARBA NP, the Rapid CARB Screen® and the Carba NP test for biochemical detection of carbapenemase-producing Enterobacteriaceae. , 2015, The Journal of antimicrobial chemotherapy.

[34]  S. Ramos,et al.  5-Lipoxygenase Deficiency Impairs Innate and Adaptive Immune Responses during Fungal Infection , 2012, PloS one.

[35]  Samir N. Patel,et al.  Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; approved guideline , 2006 .

[36]  V. Miriagou,et al.  Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[37]  Siguo Liu,et al.  Complete sequence of the bla(NDM-1)-carrying plasmid pNDM-AB from Acinetobacter baumannii of food animal origin. , 2013, The Journal of antimicrobial chemotherapy.

[38]  Mary Jane Ferraro,et al.  Performance standards for antimicrobial susceptibility testing : twelfth informational supplement , 2002 .

[39]  S. Amyes,et al.  OXA β-Lactamases , 2014, Clinical Microbiology Reviews.

[40]  A. Carattoli Animal reservoirs for extended spectrum β-lactamase producers , 2008 .

[41]  Efsa Publication,et al.  EFSA BIOHAZ Panel (EFSA Panel on Biological Hazards), 2013. Scientific Opinion on Carbapenem resistance in food animal ecosystems , 2014 .

[42]  F. Baquero,et al.  In Vitro Activities of Ertapenem (MK-0826) against Recent Clinical Bacteria Collected in Europe and Australia , 2001, Antimicrobial Agents and Chemotherapy.

[43]  Andrés Moya,et al.  Virulence factor rtx in Legionella pneumophila, evidence suggesting it is a modular multifunctional protein , 2008, BMC Genomics.

[44]  Y. Carmeli,et al.  Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[45]  L. Dijkshoorn,et al.  The Population Structure of Acinetobacter baumannii: Expanding Multiresistant Clones from an Ancestral Susceptible Genetic Pool , 2010, PloS one.

[46]  M. Augenbraun,et al.  Success of an Infection Control Program to Reduce the Spread of Carbapenem-Resistant Klebsiella pneumoniae , 2009, Infection Control & Hospital Epidemiology.

[47]  T. Mahjoub,et al.  CTLA-4 gene polymorphisms and risk of idiopathic recurrent pregnancy loss in a Tunisian population , 2014, BMC Genomics.

[48]  Qijing Zhang,et al.  Identification of New Delhi Metallo-β-lactamase 1 in Acinetobacter lwoffii of Food Animal Origin , 2012, PloS one.

[49]  M. Facciotti,et al.  An Integrated Pipeline for de Novo Assembly of Microbial Genomes , 2012, PloS one.

[50]  B. Berçot,et al.  Carbapenemase-producing Acinetobacter spp. in Cattle, France , 2012, Emerging infectious diseases.

[51]  F. Rodríguez-Valera,et al.  Development of a Multilocus Sequence Typing Scheme for Characterization of Clinical Isolates of Acinetobacter baumannii , 2005, Journal of Clinical Microbiology.

[52]  P. Nordmann,et al.  Rapid Detection of Carbapenemase-producing Enterobacteriaceae , 2012, Emerging infectious diseases.

[53]  K. Bush,et al.  The ABCD’s of β-lactamase nomenclature , 2013, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.